Stephen Ellis

Strengthening Canada's tobacco control strategy and National Tobacco control programs. Promotion of positive public health initiatives and achievements Personal Information Protection and Electronic Document (PIPEDA) with regard to improvements to privacy of health information. Oral health programs and policies related to prevention and care of children's oral health in indigenous communities. Iso Technical Committee 106 with regard to the creation of international standards for dental devices and materials. Investment from the Government of Canada in order to regulate and facilitate the development of Electronic Health Records (EHRs). Increased investment and improved regulations to protect and enhance the oral health of Canadians Indigenous Children. Increased funding for research to help improve oral health for Canadians. Increased funding for Canadian Faculties of Dentistry with regard to dental education. Increased funding and federal leadership to improve provincially funded dental programs for persons with disabilities. Increased funding and administration of oral health care for seniors living independently and in long term care facilities. Improvements to non-insured health benefits and dental program in order to enhance the oral health status of patients accessing the program. Federal Budgetary Process with regards to funding of dental care. As well as pre budget consultation with regard to Federal investments of taxation changes to improve the oral health care of Canadians and practice environment for dentists. Excise Tax Act: GST and Dental Services: Changes to the application of the GST (Zero-rate) on Dental Practices. Discuss the negative impact and strain that taxing employer provided health benefits would have on the health of Canadian and on the provincially funded healthcare system. Discussing the importance regarding regulations surrounding food and beverage marketing to young children, as well as food labeling and healthy eating for Canadians, and its positive impact on oral health. Chemical Management Plan: The Challenge process with regards to the regulation of Bisphenol A in oral health care. Canadian Environment Protection Act - Mercury-ROMS (Risk Management Strategy) with regards to safe disposal of dental amalgam waste.

HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, internationally trained dentists, administrative staffing. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA): PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information NATIONAL TOBACCO CONTROL PROGRAMS: Strengthening Canada's tobacco control strategy INDIGENOUS ORAL HEALTH: Programs and policies related to prevention and care to improve the oral health of Indigenous peoples. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investment and improved regulations to protect and enhance the oral health of Canadians HEALTH INFORMATION TECHNOLOGIES (ELECTRONIC HEALTH RECORDS): Investment and needed regulations to facilitate the development of EHRs in Canada FLUORIDE: promotion of positive public health initiatives and achievements CAPITAL GAINS TAX: to discuss the impact that the recent changes to the capital gains tax regulations have on Canadian dentists and to advocate for amendments and/or exemptions that would mitigate the adverse effects. ORAL HEALTH RESEARCH, ACCESS AND DATA: increased funding for research and projects to help improve the oral health of Canadians, such as filing of submissions and advocacy for improvements to the Oral Health Access Fund DENTAL EDUCATION: Increase funding for Canadian Faculties of Dentistry PRE-BUDGET CONSULTATIONS: Federal investments or taxation changes to improve the oral health care of Canadians and practice environment for dentists PERSONS WITH DISABILITIES: increased funding and federal leadership to improve provincially funded dental programs for persons with disabilities. SENIORS ORAL HEALTH: funding and administration of oral health care for seniors living independently and in long term care facilities NON INSURED HEALTH BENEFITS: Improvement to the dental program in order to enhance the oral health status of patients accessing the program. TAXATION OF HEALTH BENEFITS: to discuss the negative impact and strain that taxing employer provided health benefits would have on the health of Canadians and on the provincially funded healthcare system. MARKETING TO KIDS: Sugar/Healthy Eating: to discuss the importance regarding regulations and legislation, Including Bill C-252, surrounding food and beverage marketing to young children. Healthy Eating: to discuss the issue of food labeling and healthy eating for Canadians and its positive impact on oral health. DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan. DE-INSURANCE: To discuss the potential impact of the Canadian Dental Care Plan (CDCP) on employer-provided dental coverage and to advocate for a range of strategies that prevent employers from dropping their dental benefits, including but not limited to tax credits and changes in eligibility requirements. ANTI INDIGENOUS RACISM IN HEALTH: discussions to promote the Truth and Reconciliation Calls to Action as they relate to Health, such as funding for cultural safety programs in dentistry. Iso Technical Committee 106 with regard to the creation of international standards for dental devices and materials. Excise Tax Act: GST and Dental Services: Changes to the application of the GST (Zero-rate) on Dental Practices. Chemical Management Plan: The Challenge process with regards to the regulation of Bisphenol A in oral health care. Canadian Environment Protection Act - Mercury-ROMS (Risk Management Strategy) with regards to safe disposal of dental amalgam waste.

EXCISE TAX ACT: GST AND DENTAL SERVICES: Changes to the application of the GST (zero-rate) on Dental practices FLUORIDE: promotion of positive public health initiatives and achievements CAPITAL GAINS TAX: to discuss the impact that the recent changes to the capital gains tax regulations have on Canadian dentists and to advocate for amendments and/or exemptions that would mitigate the adverse effects. PRE-BUDGET CONSULTATIONS: Federal investments or taxation changes to improve the oral health care of Canadians and practice environment for dentists HEALTH INFORMATION TECHNOLOGIES (ELECTRONIC HEALTH RECORDS): Investment and needed regulations to facilitate the development of EHRs in Canada PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA): PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information NATIONAL TOBACCO CONTROL PROGRAMS: Strengthening Canada's tobacco control strategy NON INSURED HEALTH BENEFITS: Improvement to the dental program in order to enhance the oral health status of patients accessing the program. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investment and improved regulations to protect and enhance the oral health of Canadians SENIORS ORAL HEALTH: funding and administration of oral health care for seniors living independently and in long term care facilities DENTAL EDUCATION: Increase funding for Canadian Faculties of Dentistry DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan. CHEMICAL MANAGEMENT PLAN: The Challenge Process, with regard to regulation of Bisphenol A in oral health care. HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, internationally trained dentists, administrative staffing. MARKETING TO KIDS: Sugar/Healthy Eating: to discuss the importance regarding regulations and legislation, Including Bill C-252, surrounding food and beverage marketing to young children. Healthy Eating: to discuss the issue of food labeling and healthy eating for Canadians and its positive impact on oral health. INDIGENOUS ORAL HEALTH: Programs and policies related to prevention and care to improve the oral health of Indigenous peoples. CEPA (Canadian Environment Protection Act) - Mercury- ROMS (Risk Management Strategy) with regard to safe disposal of dental amalgam waste. DE-INSURANCE: To discuss the potential impact of the Canadian Dental Care Plan (CDCP) on employer-provided dental coverage and to advocate for a range of strategies that prevent employers from dropping their dental benefits, including but not limited to tax credits and changes in eligibility requirements. ANTI INDIGENOUS RACISM IN HEALTH: discussions to promote the Truth and Reconciliation Calls to Action as they relate to Health, such as funding for cultural safety programs in dentistry. ORAL HEALTH RESEARCH, ACCESS AND DATA: increased funding for research and projects to help improve the oral health of Canadians, such as filing of submissions and advocacy for improvements to the Oral Health Access Fund ISO TECHNICAL COMMITTEE 106: creation of international standards for dental devices and materials TAXATION OF HEALTH BENEFITS: to discuss the negative impact and strain that taxing employer provided health benefits would have on the health of Canadians and on the provincially funded healthcare system.

Increased funding for Canadian Faculties of Dentistry with regard to dental education. Increased investment and improved regulations to protect and enhance the oral health of Canadians Indigenous Children. Investment from the Government of Canada in order to regulate and facilitate the development of Electronic Health Records (EHRs). HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, internationally trained dentists, administrative staffing. NON INSURED HEALTH BENEFITS: Improvement to the dental program in order to enhance the oral health status of patients accessing the program. MARKETING TO KIDS: Sugar/Healthy Eating: to discuss the importance regarding regulations and legislation, Including Bill C-252, surrounding food and beverage marketing to young children. Healthy Eating: to discuss the issue of food labeling and healthy eating for Canadians and its positive impact on oral health. INDIGENOUS ORAL HEALTH: Programs and policies related to prevention and care to improve the oral health of Indigenous peoples. DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan. DE-INSURANCE: To discuss the potential impact of the Canadian Dental Care Plan (CDCP) on employer-provided dental coverage and to advocate for a range of strategies that prevent employers from dropping their dental benefits, including but not limited to tax credits and changes in eligibility requirements. CAPITAL GAINS TAX: to discuss the impact that the recent changes to the capital gains tax regulations have on Canadian dentists and to advocate for amendments and/or exemptions that would mitigate the adverse effects. Federal Budgetary Process with regards to funding of dental care. As well as pre budget consultation with regard to Federal investments of taxation changes to improve the oral health care of Canadians and practice environment for dentists. Improvements to non-insured health benefits and dental program in order to enhance the oral health status of patients accessing the program. Iso Technical Committee 106 with regard to the creation of international standards for dental devices and materials. Oral health programs and policies related to prevention and care of children's oral health in indigenous communities. Promotion of positive public health initiatives and achievements Strengthening Canada's tobacco control strategy and National Tobacco control programs. DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan.

DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan and the Interim Federal Health Program. HEALTH HUMAN RESOURCES: discussions on addressing health human resources challenges within dentistry, including challenges in remote areas, the Canada student loan forgiveness, Canada Student Grant, PGWP for dental assistants, internationally trained dentists, administrative staffing. US Tariffs: working with the federal government to advocate on minimizing the impact of tariffs on access to dental care in Canada. DE-INSURANCE: To discuss the potential impact of the Canadian Dental Care Plan (CDCP) on employer-provided dental coverage and to advocate for a range of strategies that prevent employers from dropping their dental benefits, including but not limited to tax credits and changes in eligibility requirements. TAXATION OF HEALTH BENEFITS: to discuss the negative impact and strain that taxing employer provided health benefits would have on the health of Canadians and on the provincially funded healthcare system. SENIORS ORAL HEALTH: funding and administration of oral health care for seniors living independently and in long term care facilities PRE-BUDGET CONSULTATIONS: Federal investments or taxation changes to improve the oral health care of Canadians and practice environment for dentists PERSONS WITH DISABILITIES: increased funding and federal leadership to improveprovincially funded dental programs for persons with disabilities. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA): PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information ORAL HEALTH RESEARCH, ACCESS AND DATA: increased funding for research and projects to help improve the oral health of Canadians, such as filing of submissions and advocacy for improvements to the Oral Health Access Fund NON INSURED HEALTH BENEFITS: Improvement to the dental program in order to enhance the oral health status of patients accessing the program. NATIONAL TOBACCO CONTROL PROGRAMS: Strengthening Canada's tobacco control strategy MARKETING TO KIDS: Sugar/Healthy Eating: to discuss the importance regarding regulations and legislation, Including Bill C-252, surrounding food and beverage marketing to young children. Healthy Eating: to discuss the issue of food labeling and healthy eating for Canadians and its positive impact on oral health. ISO TECHNICAL COMMITTEE 106: creation of international standards for dental devices and materials INDIGENOUS ORAL HEALTH: Programs and policies related to prevention and care to improve the oral health of Indigenous peoples. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investment and improved regulations to protect and enhance the oral health of Canadians HEALTH INFORMATION TECHNOLOGIES (ELECTRONIC HEALTH RECORDS): Investment and needed regulations to facilitate the development of EHRs in Canada FLUORIDE: promotion of positive public health initiatives and achievements EXCISE TAX ACT: GST AND DENTAL SERVICES: Changes to the application of the GST (zero-rate) on Dental practices DENTAL EDUCATION: Increase funding for Canadian Faculties of Dentistry CHEMICAL MANAGEMENT PLAN: The Challenge Process, with regard to regulation of Bisphenol A in oral health care. CEPA (Canadian Environment Protection Act) - Mercury- ROMS (Risk Management Strategy) with regard to safe disposal of dental amalgam waste. CAPITAL GAINS TAX: to discuss the impact that the recent changes to the capital gains tax regulations have on Canadian dentists and to advocate for amendments and/or exemptions that would mitigate the adverse effects. ANTI INDIGENOUS RACISM IN HEALTH: discussions to promote the Truth and Reconciliation Calls to Action as they relate to Health, such as funding for cultural safety programs in dentistry.

That the federal government support the oral health care sector in addressing critical workforce challenges. That the federal government take steps to mitigate the risk of employers dropping their insurance plans for employees. Bill C-252, An Act to amend the Food and Drugs Act, prohibiting the marketing of certain unhealthy foods and beverages to children 13 years of age or younger. Looking to have the federal government prioritize and advance Canada's Healthy Eating Strategy, including fully implementing restrictions on unhealthy food advertising to children. DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan. Increased funding for Canadian Faculties of Dentistry with regard to dental education. Increased investment and improved regulations to protect and enhance the oral health of Canadians Indigenous Children. Investment from the Government of Canada in order to regulate and facilitate the development of Electronic Health Records (EHRs). Increased funding and administration of oral health care for seniors living independently and in long term care facilities. Increased funding and federal leadership to improve provincially funded dental programs for persons with disabilities. Increased funding for research to help improve oral health for Canadians. Federal Budgetary Process with regards to funding of dental care. As well as pre budget consultation with regard to Federal investments of taxation changes to improve the oral health care of Canadians and practice environment for dentists. Improvements to non-insured health benefits and dental program in order to enhance the oral health status of patients accessing the program. Iso Technical Committee 106 with regard to the creation of international standards for dental devices and materials. Oral health programs and policies related to prevention and care of children's oral health in indigenous communities. Promotion of positive public health initiatives and achievements Strengthening Canada's tobacco control strategy and National Tobacco control programs. Chemical Management Plan: The Challenge process with regards to the regulation of Bisphenol A in oral health care. Discuss the negative impact and strain that taxing employer provided health benefits would have on the health of Canadian and on the provincially funded healthcare system. Discussing the importance regarding regulations surrounding food and beverage marketing to young children, as well as food labeling and healthy eating for Canadians, and its positive impact on oral health. Canadian Environment Protection Act - Mercury-ROMS (Risk Management Strategy) with regards to safe disposal of dental amalgam waste. Excise Tax Act: GST and Dental Services: Changes to the application of the GST (Zero-rate) on Dental Practices. Personal Information Protection and Electronic Document (PIPEDA) with regard to improvements to privacy of health information.

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of Electronic Health Records and Electronic Medical Records in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients. PERSONAL

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure. MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives on medical assistance in dying. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. INDIGENOUS HEALTH AND RECONCILIATION WITH INDIGENOUS PEOPLES: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, and committing to collaborative and respectful relationships with Indigenous patients and communities. The CMA is also advocating to increase trust between Ind

The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. THE ACQUISITION AND THE DOMESTIC SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT FOR HEALTH CARE PROVIDERS: Ensuring the federal government take additional measures ensure adequate supply, proper distribution, and appropriate usage of personal protective equipment throughout health systems. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to

TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Cauc

HEALTH HUMAN RESOURCES: Increasing the number of doctors and nurses. HEALTH HUMAN RESOURCES: Increasing access to virtual primary care for all people living in Canada. HEALTH HUMAN RESOURCES: Improving workforce data collection across health systems. HEALTH HUMAN RESOURCES: Ensuring that every Canadian has access to a family doctor or primary health team. HEALTH HUMAN RESOURCES: Developing a strategy to support the mental health of health care workers and their families. HEALTH HUMAN RESOURCES: Developing an action plan to get internationally trained doctors, nurses and nurse practitioners to work. PAN-CANADIAN LICENSURE FOR REGULATED HEALTH PROFESSIONALS: Seeking federal government support, including studies and investment, to explore barriers and enablers for pan-Canadian licensure, including enabling legislation in the provinces and territories HEALTH WORKFORCE PLANNING: Invest in pan-Canadian health workforce planning, including data infrastructure, and a physician supply needs-based planning tool, to ensure Canadians have timely access to health providers while supporting the well-being of health workers. HEALTH HUMAN RESOURCES: advocating for federal leadership, in collaboration with the provinces and territories, to address the health human resources crisis, with new federal measures including creating retention incentives and addressing administrative burden to improve access to healthcare in areas of need and improve the well-being of health care providers.

THE IMPLEMENTATION OF A NATIONAL MENTAL HEALTH SUPPORT SERVICE FOR HEALTH CARE WORKERS: Establish an emergency National Mental Health Support Services hotline for all health care providers during the pandemic, to ensure health care providers have the assistance they need to deal with an increasing patient load THE ACQUISITION AND THE DOMESTIC SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT FOR HEALTH CARE PROVIDERS: Ensuring the federal government take additional measures ensure adequate supply, proper distribution, and appropriate usage of personal protective equipment throughout health systems SUPPORT FOR ESSENTIAL WORKERS: Advocacy on paid sick leave for essential workers to support Canada's pandemic response SICK NOTES: Advocacy on discontinuing the requirement that employees present sick notes to their employers SAFETY OF HEALTH CARE WORKERS AND PATIENTS: Advocate for the implementation, by all applicable jurisdictions, of measures to protect health care workers and anyone seeking health care treatment from violence, threats, intimidation, and harassment SAFE AND UNIMPEDED ACCESS TO HEALTH CARE FACILITIES: Ensuring safe and unimpeded access to health care facilities for health care workers and patients RECONCILIATION WITH INDIGENOUS PEOPLES IN CANADA: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, advancing compensation for Indigenous children and committing to collaborative and respectful relationships with Indigenous patients and communities PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information PAN-CANADIAN LICENSURE FOR REGULATED HEALTH PROFESSIONALS: Seeking federal government support, including studies and investment, to explore barriers and enablers for pan-Canadian licensure PALLIATIVE AND END OF LIFE CARE: Improved national standards and investment in the area of palliative and end of life care. OLDER ADULTS CARE BENEFIT: New older adults care benefit program to deliver funding to older adults and caregivers to cover out of pocket health care costs NATIONAL TOBACCO CONTROL PROGRAMS: Increased restriction on the sale and advertising of tobacco and vaping products in Canada NATIONAL PHYSICIANS DAY: CMA is advocating for a National Physicians Day in Canada MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives as part of the parliamentary review required by Bill C-7 LONG-TERM CARE & SENIORS: Support older persons in Canada to age with dignity, including federal investment in national standards for long-term care and enhanced home and community care INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada HEALTH WORKFORCE PLANNING: Invest in pan-Canadian health workforce planning, including data infrastructure, and a physician supply needs-based planning tool, to ensure Canadians have timely access to health providers while supporting the well-being of health workers HEALTH PROMOTION AND DISEASE PREVENTION: Increased investment and improved regulations to protect and enhance the health of Canadians HEALTH INFRASTRUCTURE: A targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure HEALTH INFORMATION TECHNOLOGIES (ELECTRONIC MEDICAL AND HEALTH RECORDS: Investment and needed regulations to facilitate the development of EHRs and EMRs in Canada HEALTH HUMAN RESOURCES: Recruitment and retention of health care providers and federal investment in residency spots HARMFUL ONLINE CONTENT: Advocate for new legislative measures to address the escalation of online harassment, intimidation, and threats of violence targeting

International trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Internal trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Funding for programs to be operated by the Canadian Cancer Society to advance cancer control. Canadian Partnership Against Cancer, as it relates to continued federal funding for the cancer control strategy Canada Health Transfer and health system bilateral funding agreements intended for provinces/territories to support the delivery of healthcare services Framework Convention on Tobacco Control, including protocols, guidelines and implementation Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement Non-Smokers' Health Act including implementation and enforcement Food and Drugs Act and regulations, as it relates to nciotine replacement products Federal Tobacco Control Strategy, including all matters related to tobacco control Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer. Communication regarding alcohol consumption guidance. Food and Drugs Act and regulations, as it relates to alcohol warning labels Food and Drugs Act and regulations, as it relates to restricting the advertising to children of foods high in sodium, sugars and saturated fat. Healthy Living - Supporting initiatives, legislation, regulation, policies, and programs that prevent cancer or improve the social determinants of health Adoption of HPV testing and increasing HPV vaccination rates Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines Equitable and timely access to cancer screening. Measures and funding related to the charitable sector generally Equitable access to care along the full cancer continuum for First Nations, Inuit and Métis communities Employment Insurance special benefit programs, including the sickness benefit and compassionate care benefit Canada Labour Code and Employment Insurance Act, as it relates to job-protected leave, employment insurance special benefits, return to work policies, and human rights protections for people affected by cancer Access to information and support to make decisions regarding end-of-life care, including Medical Assistance In Dying Supports for mental health during people's cancer journeys Implementation and funding of the National Grief Action Plan as part of the government's work on palliative care and mental health Canada Health Act as it relates to access to care, including long-term, home, and palliative care National Caregiving Strategy Financial supports for caregivers, including the Canada Caregiver Credit Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people Setting and measuring pan-Canadian wait time benchmarks and targets and measures to address them, including addressing healthcare shortages, increased and sustainable funding for care, infrastructure and equipment, targeted strategic funding to PTs for workforce shortages, particularly in rural and remote communities. Sustained core funding for federal research agencies, improved coverage of indirect research costs, Canadian research sovereignty, strengthening capacity and the economic benefits of domestic research, research commercialization. Increasing access to care including models of care, removing barriers to care, particularly for underserved communities, using innovative approaches to improve access to care including AI to improve timely diagnosis and treatment. Issu

Advocate for changes to facilitate adoption of auto features for retirement savings. Advocate for legislative or regulatory changes to allow for automatic features in workplace pension plans. Discussions related to the implementation of CRA Notice 344 Consultation on the National Strategy on mental health of men and boys Discussions related to Bill S-5 Connected Care for Canadians Act. FCAC direction to update complaint-handling information for insurers Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB) Discussions related to supply and shortages of drugs in Canada, including the Multi-Stakeholder Steering Committee. Discussions related to regulatory burden, including “cutting red tape”. Impacts on Canadian insurers of proposed U.S. tax measures. Discussions relating to the efficiency and effectiveness of the financial sector regulatory system as it pertains to insurance companies. Discussing plans on the Data Collection Modernization initiative Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs) Statutory review of the Insurance Companies Act as it relates to insurance products and investments. Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Promotion of pension products, including decumulation solutions. Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services. Inter-provincial harmonization and trade barriers as it relates to insurance products. Discussions related to the financial sector policy review. Office of the Superintendent of Financial Institutions (OSFI). Guidelines related to risk management, capital and accounting for insurance companies. This includes capital charges for infrastructure investments under the LICAT. International Trade with respect to opening trade relations, regulations, foreign ownership and national treatment in foreign markets, with regards to India, Europe, China, Japan, Trans-Pacific partnership (TPP), Canada-United States-Mexico Agreement (CUSMA), Plurilateral Trade In Services Agreement (TISA) and the World Trade Organization (WTO). Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage. Promotion of risk-based and principles-based regulation for financial institutions regulations. Personal Information Protection and Electronic Documents Act: seeking workable approaches to privacy rules affecting life and health insurers when the Act is updated. Income Tax Regulations (section 6(1)(f) as it relates to income tax withholding on wage loss replacement plans (disability income benefits). Income Tax Regulations, Part XIV. Income Tax Regulations, Part III: Updating income tax rules for life insurance policies. Income Tax Act, Section 146: Retirement income recommendations regarding the treatment of life insurance companies; Section 146.2 (TFSAs); Section 146.3 (RRIFs). Income Tax Act, Part VI as it relates to capital tax on financial institutions. Financing infrastructure projects, as it relates to investments by insurers Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) risk-based guidance as it relates to life insurance Employment Insurance (EI) reform as it relates to disability benefits; and EI Premium Reduction Program issues. Amendments to Proceeds of Crime (Money Laundering) and Terrorist Financing rules as they affect insurance companies

Tariffs. The ODA is supporting the Canadian Dental Association’s efforts to ensure that tariffs do not impact Canadians' oral health and give suppliers time to restructure their supply chains. This includes requests for exemptions for essential dental projects, implementing sufficient notice, and methods to support domestic production. The Canadian Dental Care Plan -- specifically the ODA is working with the Canadian Dental Association (CDA) and the provincial and territorial dental associations to engage the Government of Canada on the national dental care program for low-income Canadians. The ODA's advocacy objectives include: protecting Canadians' dental benefits and addressing staff shortages; clearing backlogs and barriers to treatment; and sustainable, durable, and long-term investments in dental care. Indigenous Services Canada including the Non-Insured Health Benefits (NIHB) for First Nations and Inuit, including the types of covered services and reimbursement for dentists; and all issues related to the Sioux Lookout Zone Dental Services Program and the Sioux Lookout Zone Dental Hygiene Services Programs.

Regulations affiliated with the Cannabis Act regarding the legalization of cannabis and regulatory amendments related to phytocannabinoids to allow CBD products to be sold as Natural Health Product Oppose amendments to the Food and Drugs Act to extend powers brought in under the 'ProtectCanadians from Unsafe Drugs Act (Vanessa’s Law)' to regulate natural health products. Natural Health Products Regulations – advocacy for fair and consistent interpretation by the regulator. Ensuring plain Language Labeling under the self-care products framework is fair. Advocacy against allowing personal importation of natural health products. Amendments to the Food and Drugs Act – Ensure sensible rules for natural health products. Address prohibition on sampling of natural health products directly to the consumer. Implication of Health Canada’s proposed Consumer Health Products Framework. Consideration of the 53 recommendations made in 1998 by the Standing Committee on Health.

Labelling as it relates to the Cannabis Act. Regulatory Amendments relating to the Natural Health Products Regulations and Food and Drug Regulations.

Trade and Export Promotion Programs, including the AgriMarketing Program and Global Affairs Canada’s Trade Commissioner Service, with respect to increasing export opportunities for Canadian natural health and wellness products Safe Food for Canadians Regulations –Impact on Organic Product Regulations. Impact on GMO labelling for foods. Impact on small businesses. Regulations affiliated with the Cannabis Act regarding the legalization of cannabis; regulatory amendments related to phytocannabinoids Natural Health Products Regulations – fair and consistent interpretation by the regulator. Plain Language Labeling under the self-care products framework. Personal importation of natural health products. Food Directorate and Canadian Food Inspection Agency – draft guidance on foods/supplemented foods/nutrition facts/food labelling and label modernization. GMO mandated labelling for food. Food & Drug Regulation - ensure appropriate interpretation of regulations. Impact on GMO labelling for food. Amendments to the Food and Drugs Act – Ensure sensible rules for natural health products. Address prohibition on sampling of natural health products directly to the consumer. Implication of Health Canada’s proposed Consumer Health Products Framework. Consideration of the 53 recommendations made in 1998 by the Standing Committee on Health.

Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system. The importance of family medicine research and the impact it has on family medicine, primary care and the health care system. Want to ensure that family medicine research is acknowledged by federal officials as requiring sufficient supports. Scopes of Practice and collaborative care: support for enhanced intra- and inter-professional collaboration Public Health: support for family physician involvement in not only playing a pivotal role in the delivery of public health but also in planning for public health emergencies. Family physicians and their practices are essential in contributing pandemic response and are fundamental partners in supporting large-scale vaccination rollout in all provinces and territories - both as a source of accurate information and delivery points for vaccines. Patient's Medical Home (PMH): identified by its patients as the place that serves as the home base or central hub for the timely provision and/or coordination of all their health and medical care needs. Implementation of PMH is desired across Canada, including appropriate integration of virtual care and its application as a part of longitudinal relationship-based care in alignment with the PMH vision. Looking for support for and understanding of the role of social determinants of health (SDoH) and how these determinants, such as poverty, impact Canadians. The CFPC continues to call attention to SDoH, the role family physicians play and the expectations we have of federal decision-makers to acknowledge SDoH when crafting policies and programs. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. The CFPC maintains strong support of the proposed National Consortium for Indigenous Medical Education involving medical learners, educators, and physicians to ensure that training and continued professional development in caring for Indigenous patients are delivered through a lens of cultural humility and cultural safety. Health Human Resources: encourage support for the College of Family Physician's goal of every Canadian having their own family physician. The College of Family Physicians of Canada is also recommending increased federal support for a pan-Canadian health human resources plan to strengthen primary care. Investment into Primary Health Care Transition Fund would help improve Canada-wide access to family practices and allied primary care.

Support family doctors with teams, as that is a key enabler to providing high quality primary care. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms.

Connected Care for Canadians Act (BILL S-5) : Urging federal policy makers to adopt this legislation quickly and to ensure that it is supported by a robust set of regulations. Provide CFPC's perspective on Federal Budget 2025's initiative to “Improving Access to Health Care in the Arctic and the North”. Funds should be directed to supporting family practices, as part of the Federal government's Health Infrastructure Fund announced in Budget 2025. Fulfill key investments to support family doctors, promised by the Liberal Party during the 2025 Federal elections. This includes initiatives to provide admin burden relief, set up a new FP practice fund, and create new residency seats. Indigenous Health: support for health care initiatives and education that improve health outcomes for Indigenous people of Canada and address the adverse effects of systemic racism, in line with the Truth and Reconciliation Commission of Canada’s calls for action. Support family doctors with teams, as that is a key enabler to providing high quality primary care Fund CFPC efforts to streamline foreign credential recognition of internationally educated family physicians to bolster the health workforce. Invest in family medicine by adding new family doctors and directing funding to expand training, have fair compensation, and other recruitment/retention measures. Addressing administrative burden: Administrative burden consistently ranks as a top concern for family physicians. This time comes in the way of providing patient care. One of the significant sources of administrative burden for family physicians is filling out federal health forms. Universal Pharmacare - We advocate for universal national single payer program for prescription medication that would improve coverage across Canada and result in logistical efficiencies for the system.

Policies or Program • Connect with government officials to discuss opportunities to support Canada's health care system and to improve seniors care in Canada. Grant, Contribution or Other Financial Benefit • To advocate for future budgetary funding for the Canadian Association for Long Term Care, including funding for health human resources and long-term care infrastructure support, as well as funding and other supports for COVID-19 related challenges.

To advocate for future budgetary funding for the Canadian Association for Long Term Care, including funding for health human resources and long-term care infrastructure support, as well as funding and other supports for COVID-19 related challenges. Connect the Canadian Association for Long Term Care with government officials to discuss opportunities to support Canada's health care system and to improve seniors care in Canada.

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry

World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) The government's Science and Technology strategy as it relates to the biopharmaceutical industry Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations Smart Regulations as it relates to the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Proposed pharmacare legislation related to any future national pharmacare program Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products New Substances Notification Regulations as it relates to the biopharmaceutical industry Income Tax Act as it relates to biopharmaceutical products Health Canada’s Interim Orders relating to COVID-19: The Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19; The Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19; The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19; The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade treaty agreement as they relate to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Canada's Food and Consumer Safety Action Plan as it relates to the regulation and protection of biopharmaceutical products Canada's Access to Medicines Regime with respect to ensuring that the program allows for the deli

World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) The government's Science and Technology strategy as it relates to the biopharmaceutical industry Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations Smart Regulations as it relates to the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products New Substances Notification Regulations as it relates to the biopharmaceutical industry Income Tax Act as it relates to biopharmaceutical products Health Canada’s Interim Orders relating to COVID-19: The Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19; The Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19; The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19; The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade treaty agreement as they relate to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Canada's Food and Consumer Safety Action Plan as it relates to the regulation and protection of biopharmaceutical products Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a b

Inclusion of OTs as mental health support providers within internal and external government commu ications regarding mental health. The inclusion of occupational therapists on all Primary Care Teams in communities across Canada re health system innovation and transformation. Advocating for OTs to be designated mental health providers. Inclusion of occupational therapy in extended health benefits in public insurance plans; refugee health; veterans health; Indigenous people's health. Easier access to Non Insured Health Benefits Program, and Jordan's Principle funding by streamlining the application and approval process. Importance of occupational therapy interventions to support the Armed Forces and Veterans Promote the creation of a source of funding for occupational therapy research We are advocating for mental health investments, occupational therapy inclusion in primary care, changes to the Non-Insured Health Benefits (NIHB) Program and Jordan's Principle Program. CAOT is advocating for the inclusion of occupational therapists (OTs) on primary care teams in communities across Canada, so that OTs can provide low cost high impact interventions that result in positive health and wellness outcomes for the people of Canada. OTs provide home assessments and modifications that allow seniors for example stay at home and lead productive lives in their communities. CAOT provides its perspectives on legislation such as the implementation of Pan Canadian Framework for Palliative Care in Canada Act. Indigenous services, mental health and facilitating seniors to age at home and in their communities.

CAOT is advocating for changes to the Income Tax Act or its regulations to enable occupational therapists to complete the T2201 Disability Tax Credit Certificate. We are advocating for mental health investments, occupational therapy inclusion in primary care, changes to the Non-Insured Health Benefits (NIHB) Program and Jordan's Principle Program. The inclusion of occupational therapists on all Primary Care Teams in communities across Canada re health system innovation and transformation. Advocating for OTs to be designated mental health providers. Promote the creation of a source of funding for occupational therapy research Inclusion of occupational therapy in extended health benefits in public insurance plans; refugee health; veterans health; Indigenous people's health. Importance of occupational therapy interventions to support the Armed Forces and Veterans. Easier access to Non-Insured Health Benefits Program, and Jordan's Principle funding by streamlining the application and approval process. CAOT provides its perspectives on legislation such as the implementation of Pan Canadian Framework for Palliative Care in Canada Act. Indigenous services, mental health and facilitating seniors to age at home and in their communities. CAOT is advocating for the inclusion of occupational therapists (OTs) on primary care teams in communities across Canada, so that OTs can provide low-cost, high-impact interventions that result in positive health and wellness outcomes for the people of Canada. OTs provide home assessments and modifications that allow seniors for example to stay at home and lead productive lives in their communities.